Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine

被引:17
|
作者
Suzuki, A
Otani, K
Ishida, M
Yasui, N
Kondo, T
Mihara, K
Kaneko, S
Inoue, Y
Shibata, M
Ikeda, K
机构
[1] HIROSAKI UNIV HOSP,DEPT NEUROPSYCHIAT,HIROSAKI,AOMORI 036,JAPAN
[2] YOSHITOMI PHARMACEUT IND LTD,PHARMACEUT TECHNOL CTR,FUKUOKA,JAPAN
关键词
bromperidol; levomepromazine; metabolism; plasma concentration; reduced bromperidol; thioridazine;
D O I
10.1097/00007691-199706000-00003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Bromperidol is a close structural analog of haloperidol. The authors studied the effects of levomepromazine and thioridazine, which are frequently added to other neuroleptics as sedatives, on plasma concentrations of bromperidol and its reduced metabolite. The subjects were 26 inpatients with schizophrenia receiving bromperidol, 12 to 24 mg/day, for 1 to 19 weeks, In 10 cases, 50 mg levomepromazine per day and in nine cases, 50 mg thioridazine per day were coadministered for 1 week. In seven cases, both drugs were coadministered with greater than or equal to 2-week intervals. Plasma concentrations of bromperidol and reduced bromperidol were measured by a high-performance liquid chromatographic method. Levomepromazine (n = 17) significantly (p < 0.001) increased plasma concentrations of bromperidol (7.3 +/- 4.1 versus 10.2 +/- 4.8 ng/ml) and reduced bromperidol (1.8 +/- 1.4 versus 4.5 +/- 3.3 ng/ml). Thioridazine (n = 16) did not significantly change plasma concentrations of bromperidol (9.1 +/- 5.7 versus 8.6 +/- 5.5 ng/ml),while those of reduced bromperidol could not be measured because of interfering peaks. The current study suggests that levomepromazine, but not thioridazine, increases plasma concentrations of bromperidol and reduced bromperidol by inhibiting the metabolism of these compounds.
引用
收藏
页码:261 / 264
页数:4
相关论文
共 50 条
  • [1] No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metabolite
    Otani, K
    Ishida, M
    Yasui, N
    Kondo, T
    Mihara, K
    Suzuki, A
    Kaneko, S
    Inoue, Y
    Shibata, M
    Ikeda, K
    THERAPEUTIC DRUG MONITORING, 1997, 19 (02) : 165 - 168
  • [2] Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients
    Hanako Furukori
    T. Kondo
    Norio Yasui
    Koichi Otani
    Noboru Tokinaga
    Udai Nagashima
    Sunao Kaneko
    Yoshimasa Inoue
    Psychopharmacology, 1999, 145 : 189 - 192
  • [3] Effects of itraconazole on the steady-state plasma concentrations of bromperidol and reduced bromperidol in schizophrenic patients
    Furukori, H
    Kondo, T
    Yasui, N
    Otani, K
    Tokinaga, N
    Nagashima, U
    Kaneko, S
    Inoue, Y
    PSYCHOPHARMACOLOGY, 1999, 145 (02) : 189 - 192
  • [4] Plasma concentrations of timiperone and its reduced metabolite in the patients on timiperone
    Shimoda, K
    Someya, T
    Morita, S
    Hirokane, G
    Yokono, A
    Shibasaki, M
    Takahashi, S
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 52 (05) : 535 - 540
  • [5] Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite
    Suzuki, A
    Otani, K
    Mihara, K
    Yasui, N
    Kondo, T
    Tokinaga, N
    Furukori, H
    Kaneko, S
    Inoue, Y
    Hayashi, K
    PSYCHOPHARMACOLOGY, 1998, 135 (04) : 333 - 337
  • [6] Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metabolite
    A. Suzuki
    K. Otani
    K. Mihara
    N. Yasui
    T. Kondo
    N. Tokinaga
    H. Furukori
    S. Kaneko
    Y. Inoue
    K. Hayashi
    Psychopharmacology, 1998, 135 : 333 - 337
  • [7] NO EFFECT OF THIORIDAZINE ON PLASMA-CONCENTRATIONS OF CARBAMAZEPINE AND ITS ACTIVE METABOLITE CARBAMAZEPINE-10,11-EPOXIDE
    SPINA, E
    DAGOSTINO, AMA
    IOCULANO, MP
    OTERI, G
    FAZIO, A
    PISANI, F
    THERAPEUTIC DRUG MONITORING, 1990, 12 (05) : 511 - 513
  • [8] IDENTIFICATION OF A METABOLITE OF THIORIDAZINE AND MESORIDAZINE FROM HUMAN PLASMA
    GRUENKE, LD
    CRAIG, JC
    DINOVO, EC
    GOTTSCHALK, LA
    NOBLE, EP
    BIENER, R
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1975, 10 (02): : 221 - 225
  • [9] PLASMA CONCENTRATIONS OF THIORIDAZINE METABOLITES AND ECG ABNORMALITIES
    GOTTSCHALK, LA
    DINOVO, E
    BIENER, R
    NANDI, BR
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (02) : 155 - 157
  • [10] PLASMA PROPRANOLOL LEVELS AND THEIR EFFECT ON PLASMA THIORIDAZINE AND HALOPERIDOL CONCENTRATIONS
    GREENDYKE, RM
    KANTER, DR
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1987, 7 (03) : 178 - 182